{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fproce-the-pharmacy-practice-podcast.simplecast.com%2Fepisodes%2Fglp-1-ras-in-t2d-fmalzHFO","width":444,"version":"1.0","type":"rich","title":"GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/1694d1a5-4dc4-42fa-bc9d-4af54bc4e256/proce-podcast-glp-1-ras-in-t2d-icon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/14dfdc15-1624-4a49-877d-0a710135a74d\" height=\"200\" width=\"100%\" title=\"GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; their benefits in heart failure; and their role in the updated consensus statement from the American Diabetes Association/European Association for the Study of Diabetes."}